SKI Market

Indian Indices

Sensex

84,929.36 447.55
( 0.53%)

Global Indices

Nasdaq

48,160.46 187.60
(0.39%)

Dow Jones

6,855.87 60.11
(0.88%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,885.23 47.46
(0.48%)

Forex

USD-INR

90.25 -0.22
(-0.24%)

EUR-INR

105.87 -0.28
(-0.27%)

GBP-INR

120.72 -0.26
(-0.21%)

JPY-INR

0.58 0.00
(-0.44%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

409.0776861

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

46.28

1347.49

EPS(TTM)

Face Value()

Div & Yield %

34.23

0.44

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	286.47	285.16	254.00	219.35	208.48	169.43
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	286.47	285.16	254.00	219.35	208.48	169.43
Other Income	4.76	4.26	5.32	4.66	1.65	2.93
Stock Adjustments	-9.97	-10.36	4.77	12.53	-4.01	15.57
Total Income	281.26	279.06	264.09	236.54	206.12	187.93
EXPENDITURE :
Raw Materials	83.70	89.28	84.65	76.37	49.38	44.81
Power & Fuel Cost	10.12	12.34	9.95	8.74	6.93	7.29
Employee Cost	54.76	56.72	47.92	39.12	33.45	37.16
Other Manufacturing Expenses	14.07	14.49	7.57	6.89	5.46	6.19
Selling & Administrative Expenses	54.45	50.25	49.26	34.94	32.24	32.88
Miscellaneous Expenses	8.46	4.37	4.55	5.26	10.28	3.95
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	225.56	227.45	203.88	171.31	137.74	132.28
Operating Profit	55.71	51.60	60.21	65.23	68.37	55.64
Interest	5.37	5.09	6.50	2.47	3.95	5.03
Gross Profit	50.34	46.51	53.71	62.76	64.42	50.61
Depreciation	8.58	9.78	9.79	9.50	9.63	9.39
Profit Before Tax	41.76	36.73	43.92	53.26	54.79	41.22
Tax	11.27	9.64	10.73	14.25	16.37	11.81
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.35	-0.06	0.86	-0.51	-1.48	-1.80
Reported Net Profit	31.84	27.16	32.34	39.52	39.90	31.22
Extraordinary Items	-0.35	0.02	0.01	0.09	-3.69	0.38
Adjusted Net Profit	32.19	27.14	32.33	39.43	43.59	30.84
Adjustment below Net Profit	-0.36	-0.02	0.11	-0.16	0.21	-1.63
P & L Balance brought forward	246.53	226.20	202.25	171.40	136.90	113.25
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	5.10	6.81	8.51	8.51	5.62	5.96
P & L Balance carried down	272.91	246.53	226.20	202.25	171.40	136.90
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	70.00	60.00	80.00	100.00	100.00	66.00
Dividend Per Share(Rs)	7.00	6.00	8.00	10.00	10.00	6.60
Earnings Per Share-Unit Curr	37.43	31.93	38.02	46.45	46.90	36.70
Earnings Per Share(Adj)-Unit Curr	37.43	31.93	38.02	46.45	46.90	36.70
Book Value-Unit Curr	398.60	367.59	343.70	315.54	279.28	238.72
Book Value(Adj)-Unit Curr	398.60	367.59	343.70	315.54	279.28	238.72

84,929.36 447.55 ( 0.53%)

48,160.46 187.60 (0.39%)

6,855.87 60.11 (0.88%)

49,620.18 618.68 (1.26%)

9,885.23 47.46 (0.48%)

90.25 -0.22 (-0.24%)

105.87 -0.28 (-0.27%)

120.72 -0.26 (-0.21%)

0.58 0.00 (-0.44%)